Journal article
Outcome of patients with early-stage follicular lymphoma staged with 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy alone
SP Ng, R Khor, M Bressel, M MacManus, JF Seymour, RJ Hicks, A Wirth
European Journal of Nuclear Medicine and Molecular Imaging | SPRINGER | Published : 2019
Abstract
Purpose/objective(s): To evaluate the impact of positron emission tomography (PET) staging on overall survival (OS) and progression-free survival (PFS) in patients with early-stage (stages I and II) follicular lymphoma (ESFL) treated with radiation therapy alone. Materials/methods: Eighty-five patients with ESFL treated with curative-intent radiation therapy (RT) between December 2000 and May 2011 were identified. Of those, 13 who had no PET staging and 25 who received additional systemic therapy were excluded from the analysis. Thus, we analyzed 47 patients with PET-staged ESFL treated with definitive radiation therapy alone (dose > 23Gy). Tumour features, pre-treatment computed tomography ..
View full abstractGrants
Funding Acknowledgements
Authors Sweet Ping Ng, Richard Khor, Mathias Bressel, Michael MacManus, John F Seymour, Rodney J. Hicks, and Andrew Wirth declare that they have no conflict of interest. Sweet Ping Ng is funded by the Australian Postgraduate Award, Radiological Society of North America (RSNA) Fellow Grant, and Royal Australian and New Zealand College of Radiologists (RANZCR) Research Grant. Professor Hicks is supported by an Australian National Health and Medical Research Council Practitioner Fellowship.